Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Pulse Biosciences (PLSE)
NASDAQ:PLSE
Holding PLSE?
Track your performance easily
PLSE Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$6.60 - $22.69
Previous Close$16.12
Volume138.43K
Average Volume (3M)165.38K
Market Cap
$991.65M
Enterprise Value$920.98M
Total Cash (Recent Filing)$79.03M
Total Debt (Recent Filing)$8.37M
Price to Earnings (P/E)―
Beta1.87
Next Earnings
Mar 27, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.81
Shares Outstanding61,516,677
10 Day Avg. Volume231,097
30 Day Avg. Volume165,379
Standard Deviation0.32
R-Squared0.08
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)12.51
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-29.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-37.89
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Pulse Biosciences News
PremiumCompany Announcements
Pulse Biosciences Reports Q3 2024 Financials and Developments
PremiumCompany Announcements
Pulse Biosciences Highlights CellFX™ Advances in Presentation
PremiumCompany Announcements
Pulse Biosciences Enhances Board with Strategic Leadership Changes
Ownership Overview
71.57% Insiders
2.40% Mutual Funds
0.56% Other Institutional Investors
22.27% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
PLSE FAQ
What was Pulse Biosciences’s price range in the past 12 months?
Pulse Biosciences lowest stock price was $6.59 and its highest was $22.69 in the past 12 months.
What is Pulse Biosciences’s market cap?
Currently, no data Available
When is Pulse Biosciences’s upcoming earnings report date?
Pulse Biosciences’s upcoming earnings report date is Mar 27, 2025 which is in 124 days.
How were Pulse Biosciences’s earnings last quarter?
Pulse Biosciences released its earnings results on Oct 30, 2024. The company reported -$0.156 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.156.
Is Pulse Biosciences overvalued?
According to Wall Street analysts Pulse Biosciences’s price is currently Overvalued.
Does Pulse Biosciences pay dividends?
Pulse Biosciences does not currently pay dividends.
What is Pulse Biosciences’s EPS estimate?
Pulse Biosciences’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Pulse Biosciences have?
Pulse Biosciences has 61,516,678 shares outstanding.
What happened to Pulse Biosciences’s price movement after its last earnings report?
Pulse Biosciences reported an EPS of -$0.156 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.637%.
Which hedge fund is a major shareholder of Pulse Biosciences?
Among the largest hedge funds holding Pulse Biosciences’s share is Robert Bender&Associates. It holds Pulse Biosciences’s shares valued at N/A.
---
Pulse Biosciences Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
PLSE Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 10.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $57.3K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 0.8%
Last 30 Days ▲ 5.6%
Last 30 Days ▲ 5.6%
Technicals
SMA
Positive
20 days / 200 days
Momentum
143.87%
12-Months-Change
Fundamentals
Return on Equity
-70.28%
Trailing 12-Months
Asset Growth
41.10%
Trailing 12-Months
Company Description
Pulse Biosciences
Pulse Biosciences, Inc. is a clinical stage electroceutical, an electrical energy based therapeutic, company pursuing commercial applications of its proprietary Nano-Pulse Stimulation (NPS) technology. It manufactures surgical and medical instruments uses a novel and proprietary platform technology called Nano-Pulse Electro-Signaling. The NPES provides local tumor control and initiates an adaptive immune response with a vaccine-like effect by inducing immunogenic apoptosis of the cells. The company was founded on May 19, 2014 and is headquartered in Hayward, CA.
---
PLSE Earnings Call
Q3 2024
0:00 / 0:00
---
Technical Analysis
---